Triptolide attenuates irritable bowel syndrome via inhibiting ODC1

Irritable bowel syndrome (IBS) is a chronic disorder of the gut-brain axis with significant morbidity. Triptolide, an active compound extracted from Tripterygium wilfordii Hook F (TwHF), has been widely used a...

Source: BMC Gastroenterology - June 12, 2023 Category: Gastroenterology Authors: Ning Zhu, Liuyan Zhu, Xueliang Zhang, Chengbin Huang, Wenjun Xiang and Bingwu Huang Tags: Research Source Type: research